Real World Evidence of OncotypeDX Use and Outcomes in the US SEER Registry to Complement the Results Observed in
randomized Trials
Steven Shak, MD
Chief Scientific Officer at Genomic Health Executive Vice President of Research and Development Genomic Health I Inc.Redwood City, California
